Thus, these initial results suggest that TOX is a potential prognostic factor in survival of brain glioma, brain astrocytoma, breast cancer, skin melanoma, bladder transitional cell carcinoma, and, particularly, LUAD. This evidence concerns the gene TOX and brain glioma.